Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02237898 · ClinicalTrials.gov registry record · Phase 1
Harnessing the Power of Technology: MOMBA for Postpartum Smoking
A Phase 1 study of Smoking Cessation, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT02237898: Completed Phase 1 study of Smoking Cessation, sponsored by Yale University.
NCT02237898 is a Phase 1 study of Smoking Cessation that has completed, run by Yale University. The registered enrollment target is 26 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02237898, a Phase 1 study of Smoking Cessation, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
Through a smartphone platform, financial incentives for smoking abstinence in postpartum women can be delivered remotely, thus minimizing the need for participants to come to the office to receive traditional contingency management.
Primary Outcome
Primary Outcome - Acceptability of the delivery of financial incentives for smoking abstinence in postpartum women through a smartphone platform as compared to traditional, in office contingency management. Acceptability of the smartphone application to low-income, pregnant women defined by the percentage of women who would recommend the site to a friend. Question: "How likely is it that you would recommend MoMba LiveLong to a friend who wants to stop smoking?"
Conditions Studied
Interventions
- BEHAVIORAL MoMba Live Long app & Sensordrone™ carbon-monoxide sensor
- BEHAVIORAL Office contingency management
- DEVICE Sensordrone™ carbon-monoxide sensor
- DEVICE MoMba Live Long Smartphone application
Study Locations (1)
Connecticut
- Center for Wellbeing of Women and Mothers, 40 Temple Street, Ste 6B, Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2017-02-10 |
| Est. Completion | 2019-05-13 |
| Phase | Phase 1 |
What the finished NCT02237898 record still lists
NCT02237898 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 4 interventions - of which MoMba Live Long app & Sensordrone™ carbon-monoxide sensor is the first listed.
NCT02237898 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT02237898 about?
NCT02237898 is a clinical study titled "Harnessing the Power of Technology: MOMBA for Postpartum Smoking". Through a smartphone platform, financial incentives for smoking abstinence in postpartum women can be delivered remotely, thus minimizing the need for participants to come to the office to receive traditional contingency management.
What is the current status of trial NCT02237898?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2017-02-10. Estimated completion is 2019-05-13.
What conditions does trial NCT02237898 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT02237898?
The interventions under investigation include: MoMba Live Long app & Sensordrone™ carbon-monoxide sensor (BEHAVIORAL), Office contingency management (BEHAVIORAL), Sensordrone™ carbon-monoxide sensor (DEVICE), MoMba Live Long Smartphone application (DEVICE).
Who is sponsoring clinical trial NCT02237898?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02237898 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02237898's enrollment target sits among peer trials
26 170th of 188 higher than 19 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Overcoming Nicotine Dependence to Enable Quitting
RECRUITING · Phase 1
-
Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use
RECRUITING · Phase 1
-
Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients
RECRUITING · Phase 1
-
Contingency Management, Quitting Smoking, and ADHD
COMPLETED · Phase 1
-
A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers
COMPLETED · Phase 1
-
Intervention for Support Persons to Help Smokers Quit
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI